Cargando…

Deep RNA Sequencing Reveals Novel Cardiac Transcriptomic Signatures for Physiological and Pathological Hypertrophy

Although both physiological hypertrophy (PHH) and pathological hypertrophy (PAH) of the heart have similar morphological appearances, only PAH leads to fatal heart failure. In the present study, we used RNA sequencing (RNA-Seq) to determine the transcriptomic signatures for both PHH and PAH. Approxi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Hong Ki, Hong, Seong-Eui, Kim, Taeyong, Kim, Do Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327670/ https://www.ncbi.nlm.nih.gov/pubmed/22523601 http://dx.doi.org/10.1371/journal.pone.0035552

Ejemplares similares

Pressure-Overload Cardiac Hypertrophy Is Associated with Distinct Alternative Splicing Due to Altered Expression of Splicing Factors
por: Kim, Taeyong, et al.
Publicado: (2014)

Central role for BRAF in cardiac hypertrophy: rethinking the pathological–physiological divide
por: Altara, Raffaele, et al.
Publicado: (2023)

Functions of Autophagy in Pathological Cardiac Hypertrophy
por: Li, Zhenhua, et al.
Publicado: (2015)

VCP represses pathological cardiac hypertrophy
por: Zhou, Ning, et al.
Publicado: (2017)

Integrated Quantitative Phosphoproteomics and Cell-Based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-Related Phosphorylation Sites
por: Kwon, Hye Kyeong, et al.
Publicado: (2021)

Differential and Conditional Activation of PKC-Isoforms Dictates Cardiac Adaptation during Physiological to Pathological Hypertrophy
por: Naskar, Shaon, et al.
Publicado: (2014)

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy
por: Yang, Dan, et al.
Publicado: (2022)

Genome-wide expression patterns in physiological cardiac hypertrophy
por: Drozdov, Ignat, et al.
Publicado: (2010)

Energy Metabolism in Exercise-Induced Physiologic Cardiac Hypertrophy
por: Xiang, Kefa, et al.
Publicado: (2020)

The role of Hippo signaling pathway in physiological cardiac hypertrophy
por: Gholipour, Majid, et al.
Publicado: (2020)

CIB1 is a Regulator of Pathological Cardiac Hypertrophy
por: Heineke, Joerg, et al.
Publicado: (2010)

Tripartite motif 32 prevents pathological cardiac hypertrophy
por: Chen, Lijuan, et al.
Publicado: (2016)

Pik3ip1 Modulates Cardiac Hypertrophy by Inhibiting PI3K Pathway
por: Song, Hong Ki, et al.
Publicado: (2015)

Bioinformatics Analysis Reveals MicroRNAs Regulating Biological Pathways in Exercise-Induced Cardiac Physiological Hypertrophy
por: Xu, Jiahong, et al.
Publicado: (2017)

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2016)

Caspase Cleavage of Gelsolin Is an Inductive Cue for Pathologic Cardiac Hypertrophy
por: Putinski, Charis, et al.
Publicado: (2018)

Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy
por: Fernandez-Caggiano, Mariana, et al.
Publicado: (2020)

The Role of CD147 in Pathological Cardiac Hypertrophy Is Regulated by Glycosylation
por: Zhong, Fang-yuan, et al.
Publicado: (2022)

Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
por: Silva, Joana, et al.
Publicado: (2022)

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy
por: Hu, Lin, et al.
Publicado: (2022)

Slowing Heart Rate Protects Against Pathological Cardiac Hypertrophy
por: Sebastian, Sonia, et al.
Publicado: (2022)

Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
por: Aiyasiding, Xiahenazi, et al.
Publicado: (2022)

Fetal-Adult Cardiac Transcriptome Analysis in Rats with Contrasting Left Ventricular Mass Reveals New Candidates for Cardiac Hypertrophy
por: Grabowski, Katja, et al.
Publicado: (2015)

Identification of tissue-enriched novel transcripts and novel exons in mice
por: Hong, Seong-Eui, et al.
Publicado: (2014)

Transcriptome Analysis of Triple Mutant for OsMADS62, OsMADS63, and OsMADS68 Reveals the Downstream Regulatory Mechanism for Pollen Germination in Rice (Oryza sativa)
por: Kim, Eui-Jung, et al.
Publicado: (2021)

Deep learning reveals disease-specific signatures of white matter pathology in tauopathies
por: Vega, Anthony R., et al.
Publicado: (2021)

Multiple short‐chain dehydrogenases/reductases are regulated in pathological cardiac hypertrophy
por: Roussel, Elise, et al.
Publicado: (2018)

Carvacrol Ameliorates Pathological Cardiac Hypertrophy in Both In-vivo and In-vitro Models
por: Jamhiri, Mohabbat, et al.
Publicado: (2019)

Divergent and Overlapping Roles for Selected Phytochemicals in the Regulation of Pathological Cardiac Hypertrophy
por: Evans, Levi, et al.
Publicado: (2021)

Targeting miR-30d reverses pathological cardiac hypertrophy
por: Li, Jin, et al.
Publicado: (2022)

Deep Sequencing of the Oral Microbiome Reveals Signatures of Periodontal Disease
por: Liu, Bo, et al.
Publicado: (2012)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

Changes in glutamic oxaloacetic transaminase 2 during rat physiological and pathological cardiomyocyte hypertrophy
por: Liu, Xin, et al.
Publicado: (2023)

High-Resolution Transcriptomic Profiling of the Heart During Chronic Stress Reveals Cellular Drivers of Cardiac Fibrosis and Hypertrophy
por: McLellan, Micheal A., et al.
Publicado: (2020)

Cardiomyocyte-Specific RIP2 Overexpression Exacerbated Pathologic Remodeling and Contributed to Spontaneous Cardiac Hypertrophy
por: Yang, Jing-jing, et al.
Publicado: (2021)

E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
por: Yang, Lu-Lu, et al.
Publicado: (2022)

A novel system-level approach using RNA-sequencing data identifies miR-30-5p and miR-142a-5p as key regulators of apoptosis in myocardial infarction
por: Kim, Jin Ock, et al.
Publicado: (2018)

Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure
por: Nomura, Seitaro, et al.
Publicado: (2018)

Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy
por: Song, Chao, et al.
Publicado: (2016)

Increased afterload induces pathological cardiac hypertrophy: a new in vitro model
por: Hirt, Marc N., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_84p3o0aqk8vej7l2rdu9m9kd9r